ライフサイエンスコーパス: epilepsy surgery

1 important prognostic factors for outcomes of epilepsy surgery.

2 novel intraoperative tool for the conduct of epilepsy surgery.

3 fractory to treatment and not candidates for epilepsy surgery.

4 the seizure disorder to pharmacotherapy and epilepsy surgery.

5 identify seizure-onset zones for subsequent epilepsy surgery.

6 pediatric patients undergoing evaluation for epilepsy surgery.

7 in the neocortex of four patients undergoing epilepsy surgery.

8 predicting the long-term seizure outcome of epilepsy surgery.

9 rtion of patients who undergo evaluation for epilepsy surgery.

10 rse seizure control with pharmacotherapy and epilepsy surgery.

11 analysed in 10 children being evaluated for epilepsy surgery.

12 nter study, 396 patients underwent resective epilepsy surgery.

13 imaging, often have a favorable outcome with epilepsy surgery.

14 sive monitoring with subdural electrodes for epilepsy surgery.

15 recordings from patients being evaluated for epilepsy surgery.

16 ntracranial electrodes during evaluation for epilepsy surgery.

17 rodes were implanted for assessment prior to epilepsy surgery.

18 lobe epilepsy obtained during evaluation for epilepsy surgery.

19 oral lobe origin who were seizure-free after epilepsy surgery.

20 izure-free (SF) or not (NSF) after receiving epilepsy surgery.

21 onnectivity in TLE and examine changes after epilepsy surgery.

22 of deterioration in naming ability following epilepsy surgery.

23 ction of seizure freedom after temporal lobe epilepsy surgery.

24 onest pathology found in children undergoing epilepsy surgery.

25 sight into selecting the correct targets for epilepsy surgery.

26 g-resistant epilepsy who underwent resective epilepsy surgery.

27 ormative seizure imaging technique to tailor epilepsy surgery.

28 ereotactic EEG as part of the evaluation for epilepsy surgery.

29 es predict neuropsychological outcomes after epilepsy surgery.

30 tant in the effort to improve the success of epilepsy surgery.

31 anged postoperative naming ability following epilepsy surgery.

32 tribute to the functional changes seen after epilepsy surgery.

33 ing neuropsychological performance following epilepsy surgery.

34 terest in seizure imaging to guide resective epilepsy surgery.

35 determine neuropsychological outcomes after epilepsy surgery.

36 EEG of 20 patients that underwent resective epilepsy surgery.

37 achieved seizure control following resective epilepsy surgery.

38 mporal lobe epilepsy who underwent resective epilepsy surgery.

39 in human hippocampal biopsies obtained from epilepsy surgery.

40 slices obtained from patients who underwent epilepsy surgery.

41 ances may partially recover after successful epilepsy surgery.

42 not deter from exploring the possibility of epilepsy surgery.

43 e damage to eloquent cortex during resective epilepsy surgery.

44 n be used to delineate the resection area in epilepsy surgery.

45 will invariably be the case in those having epilepsy surgery.

46 recordings from patients who have undergone epilepsy surgery.

47 tonometry at the time of open craniotomy for epilepsy surgery.

48 standing brain recovery mechanisms following epilepsy surgery.

49 as others emphasise the numerous barriers to epilepsy surgery.

50 antitative prognoses for patients undergoing epilepsy surgery.

51 n patients who have been judged eligible for epilepsy surgery.

52 electroencephalographic analyses made before epilepsy surgery.

53 tex, selected from 13 patients who underwent epilepsy surgery.

54 epilepsy tissue and to guide the conduct of epilepsy surgery.

55 change in IQ (delta IQ) following pediatric epilepsy surgery.

56 low perioperative mortality (0.1%-0.5%) from epilepsy surgery.

57 vity intraoperatively in patients undergoing epilepsy surgery.

58 they are not considered good candidates for epilepsy surgery.

59 otypes, ultimately refining the prognosis of epilepsy surgery.

60 all ages with histopathology available after epilepsy surgery.

61 nts with temporal lobe epilepsy submitted to epilepsy surgery.

62 mor brain (NT) control samples obtained from epilepsy surgery.

63 ho underwent intracranial EEG evaluation for epilepsy surgery.

64 Nonlesional extratemporal lobe epilepsy surgery.

65 were likely to have excellent outcomes after epilepsy surgery.

66 ctable-seizure patients being considered for epilepsy surgery.

67 electroencephalographic (EEG) monitoring and epilepsy surgery.

68 8%) had an excellent outcome after resective epilepsy surgery.

69 (MRI) is a favorable prognostic finding for epilepsy surgery.

70 operative memory changes following different epilepsy surgeries.

71 atients (mean age, 12.2 years) evaluated for epilepsy surgery, 28 of whom had magnetic resonance imag

72 25 males, 28 females) who were evaluated for epilepsy surgery: 42 underwent unilateral temporal lobe

73 e German Neuropathology Reference Center for Epilepsy Surgery (59%).

74 nilateral refractory TLE patients undergoing epilepsy surgery, a validation set of 55 unilateral refr

75 of adults with epilepsy undergoing resective epilepsy surgery achieve long-term seizure freedom and m

76 tion costs and the probability of undergoing epilepsy surgery after presurgical evaluation.

77 ria were met by 43 individuals who underwent epilepsy surgery and by 73 non-surgical individuals with

78 provided evidence on the association between epilepsy surgery and children's HRQOL, with improvement

79 e outcomes have not improved over decades of epilepsy surgery and despite a multitude of models, none

80 making in some patients being evaluated for epilepsy surgery and help to explain the biological basi

81 improve planning and prognosis of selective epilepsy surgery and neuropsychological counseling in TL

82 The feasibility of epilepsy surgery and other treatments, including those t

83 es in brain function caused by temporal lobe epilepsy surgery and relate them to the disconnection fr

84 ature and causes of the presumed underuse of epilepsy surgery and the elaboration of strategies to ad

85 All 23 patients were candidates for epilepsy surgery and underwent both IAP and resting-stat

86 e is high-level evidence for the efficacy of epilepsy surgery and use of newer antiepileptic drugs fo

87 re medication withdrawal following resective epilepsy surgery and were free of seizures other than fo

88 s cohort included 312 patients who underwent epilepsy surgery and were labeled with one or more diagn

89 e most common lesion in patients who require epilepsy surgery, and approximately 50% of patients with

90 ulation-induced seizure, underwent resective epilepsy surgery, and had a postoperative follow-up >= 1

91 options included antiepileptic drug changes, epilepsy surgery, and pacemaker implantation.

92 udy discusses the challenges of MRI-negative epilepsy surgery, and the strategies in using advanced M

93 he possible implications of our findings for epilepsy surgery approaches in tuberous sclerosis.

94 gs who underwent (nonlesional) extratemporal epilepsy surgery are confined to a highly select group o

95 with focal epilepsy should be considered for epilepsy surgery as early as possible after diagnosis.

96 epileptic discharges in a patient undergoing epilepsy surgery at 1-mm spatial resolution, including a

97 e German Neuropathology Reference Center for Epilepsy Surgery at Erlangen, Germany.

98 hort study of 882 children who had undergone epilepsy surgery at Great Ormond Street Hospital.

99 epilepsy and language dominance who received epilepsy surgery at the Epilepsy Centre Erlangen, naming

100 imately inform target selection for ablative epilepsy surgery based on normative intrinsic connectivi

101 zure outcome of 693 adults who had resective epilepsy surgery between 1990 and 2010 and used survival

102 longitudinal, cohort study, patients who had epilepsy surgery between Jan 1, 2000, and Dec 31, 2012,

103 Three hundred ninety-three patients who had epilepsy surgery between January 1986 and January 1996 w

104 ity of life (HRQOL) improves after resective epilepsy surgery, but data are limited to short follow-u

105 rdings in patients undergoing assessment for epilepsy surgery, but we do not know their potential for

106 Resective epilepsy surgery can be an effective treatment for patie

107 Resective epilepsy surgery can be beneficial, particularly for pat

108 Although epilepsy surgery can be effective, it is limited by risk

109 Epilepsy surgery can be offered in a highly selected sub

110 Epilepsy surgery can eliminate seizures in patients with

111 Epilepsy surgery can lead to seizure freedom in patients

112 Of 298 consecutive epilepsy surgery candidates (between 2001 and 2006), 160

113 a Wada test in the presurgical evaluation of epilepsy surgery candidates in the light of research on

114 s part of a prospective observation study of epilepsy surgery candidates not sufficiently localized w

115 This work was part of a cohort study of epilepsy surgery candidates not sufficiently localized w

116 predicting seizure-free surgical outcome in epilepsy surgery candidates who typically require ICEEG.

117 ion with a high positive predictive value in epilepsy surgery candidates who typically require ICEEG.

118 lateralize and localize language function in epilepsy surgery candidates.

119 urce imaging (MSI) and ICEEG localization in epilepsy surgery candidates.

120 r these functions, thus reducing the risk of epilepsy surgery causing new morbidities.

121 Munari Epilepsy Surgery Center at Niguarda Hospital in Milan, I

122 llel-group clinical trial performed at 16 US epilepsy surgery centers.

123 Data were obtained from UK epilepsy surgery centres to evaluate the costs of preope

124 Ds on heterogeneous structural MRI data from epilepsy surgery centres worldwide.

125 rt operated on over a similar period in four epilepsy surgery centres, in Brazil, France, Italy, and

126 d the magnetic resonance imaging scans of an epilepsy surgery cohort.

127 valuates the cost-effectiveness of resective epilepsy surgery compared with medical management in adu

128 ver, it is uncertain how HRQOL evolves after epilepsy surgery compared with medical therapy, such as

129 evaluation and review at a multidisciplinary epilepsy surgery conference, some of these patients were

130 Epilepsy surgery consists of surgical resection of the e

131 From our epilepsy surgery database of 1988 to 1996, we selected a

132 32% of patients who were offered epilepsy surgery decided against proceeding.

133 The success or failure of an epilepsy surgery depends greatly on the localization of

134 Evaluation for epilepsy surgery disclosed two independent epileptic foc

135 participants had implantable devices; 1 had epilepsy surgery during the study.

136 s has a specific application in the field of epilepsy surgery (electroencephalographic-correlated fun

137 Because epilepsy surgery eliminates seizures in some people, we

138 vely included 18 responders to temporal lobe epilepsy surgery (Engel I-A at 12 mo follow-up) and 18 n

139 vely included 18 responders to temporal lobe epilepsy surgery (Engel I-A at 12 mo follow-up) and 18 n

140 We performed intracerebral recordings during epilepsy surgery evaluation as 20 patient-participants l

141 alized tonic-clonic seizures obtained during epilepsy surgery evaluation in 53 patients.

142 to the literature of its use in MRI-negative epilepsy surgery evaluation, which up to now remains som

143 l level in 8 patient-participants undergoing epilepsy surgery evaluation.

144 ) implanted with intracranial electrodes for epilepsy surgery evaluation.

145 ecordings and diffusion-weighted imaging for epilepsy surgery evaluation.

146 emission computed tomography in MRI-negative epilepsy surgery evaluation.

147 ven a whole hemisphere may be candidates for epilepsy surgery even when, due to microscopic malformat

148 n specimens from 9523 patients who underwent epilepsy surgery for drug-resistant seizures in 36 cente

149 ure outcome of patients undergoing resective epilepsy surgery for this condition.

150 tients, who had undergone a second resective epilepsy surgery from 1989 to 2009.

151 interest in methods to quantitatively guide epilepsy surgery from intracranial EEG (iEEG).

152 re directions for clinical implementation of epilepsy surgery genetics.

153 Individuals with auras only after epilepsy surgery had a higher COSY than those who were s

154 th drug-resistant epilepsy who had undergone epilepsy surgery had a significantly higher rate of free

155 ilarly, the focal resection in temporal lobe epilepsy surgery has been shown to lead to functional ch

156 tes, the short-term and long-term success of epilepsy surgery has not changed substantially in recent

157 10 years, the drive to improve outcomes from epilepsy surgery has stimulated widespread interest in m

158 cale microarray studies on brain tissue from epilepsy surgery have been published over the last 10 ye

159 Recent advances in epilepsy surgery have developed a resurgence of interest

160 hic (ECoG) recordings in patients undergoing epilepsy surgery have shown that functional activation i

161 trospectively, to the benefits of successful epilepsy surgery in a cohort of 105 patients.

162 this study to identify long-term outcome of epilepsy surgery in adults by establishing patterns of s

163 Neurohistology from epilepsy surgery in five patients revealed not only intr

164 patient specific computational modelling of epilepsy surgery in order to inform treatment strategies

165 Achieving complete seizure control with epilepsy surgery in refractory patients reduces the risk

166 es in brain function caused by temporal lobe epilepsy surgery in regions distant from the resection t

167 atment appears to be higher than the risk of epilepsy surgery in suitable candidates.

168 ead at onset, making them poorly amenable to epilepsy surgery in the absence of associated focal brai

169 n naming function is a common sequelae after epilepsy surgery in the language-dominant temporal lobe

170 Our data support the early consideration of epilepsy surgery in this patient group.

171 Taken together, we rationalize that epilepsy surgery, in carefully selected cases, may be co

172 n tissue from 1386 individuals who underwent epilepsy surgery, including 599 previously unpublished i

173 We aimed to determine whether successful epilepsy surgery interrupts progressive cortical thinnin

174 , than the 'Life-satisfaction' scale and the Epilepsy Surgery Inventory 55 (ESI-55) scales.

175 Our study also indicates that epilepsy surgery is a valuable alternative in the treatm

176 Epilepsy surgery is an effective treatment for refractor

177 Temporal lobe epilepsy surgery is an effective treatment option for pa

178 Resective epilepsy surgery is an established clinical intervention

179 Epilepsy surgery is an established safe and effective tr

180 Epilepsy surgery is indicated for patients with focal se

181 y are justified, and that improved access to epilepsy surgery is necessary.

182 tween MRI and EEG data, a good outcome after epilepsy surgery is possible if EEG ictal onsets are def

183 s achieving long-term freedom from seizures, epilepsy surgery is still done in a small subset of drug

184 A priority for the development of epilepsy surgery is the generation of high-level evidenc

185 Epilepsy surgery is the most effective way to achieve lo

186 Epilepsy surgery is the most effective way to control se

187 One challenge in dominant temporal lobe epilepsy surgery is to remove sufficient epileptogenic t

188 Reoperation after failed resective epilepsy surgery led to approximately 70% long-time seiz

189 surgical psychiatric comorbidities following epilepsy surgery may be another expression of this compl

190 loring of resections for children undergoing epilepsy surgery may enhance long-term memory outcome.

191 or carefully selected individuals, resective epilepsy surgery may offer the best hope for a cure.

192 500 children (248 females) who had undergone epilepsy surgery [median age at surgery = 11.9 years, in

193 It has been proposed that epilepsy surgery might alleviate these impairments by pr

194 tunity for antiseizure medication cessation, epilepsy surgery might not only halt but reverse the dow

195 When planning for epilepsy surgery, multiple potential sites for resection

196 Epilepsy surgery needs predictive features that are easi

197 bMed literature search, using the key words 'Epilepsy Surgery', 'Neuromodulation', 'Neuroablation', '

198 Understanding the impact of epilepsy surgery on the brain is crucial to improve surg

199 Few epilepsy surgery outcome data are available from series

200 ta on the prevalence outcome using the Engel Epilepsy Surgery Outcome Scale (Class I-IV), and postope

201 aded on the The International League against Epilepsy surgery outcome scale.

202 improve epileptogenic zone localization and epilepsy surgery outcomes.

203 studies show a stagnant or declining rate of epilepsy surgery over time, despite the evidence and gui

204 Consecutive epilepsy surgery patients (n = 24) from UCLA Mattel Chil

205 ingle- and multiunit spiking activity in two epilepsy surgery patients in or near the extrastriate bo

206 In paediatric epilepsy surgery patients with hemimegalencephaly (HME;

207 METHOD: We calculated COSY in 819 epilepsy surgery patients with up to 25 years follow-up.

208 sing microwire electrodes implanted in human epilepsy surgery patients.

209 After epilepsy surgery, patients with improved seizures showed

210 iminates seizures in some people, we used an epilepsy surgery population to examine how seizure contr

211 nset zone are essential to make MRI-negative epilepsy surgery possible and worthwhile for the patient

212 ting-state seizure onset zone (SOZ)-targeted epilepsy surgery, postoperative resting-state functional

213 These results provide evidence of epilepsy surgery preventing further cerebral damage and

214 Thus, successful epilepsy surgery prevents progressive cortical atrophy t

215 imental evidence for selectively considering epilepsy surgery prior to drug resistance.

216 ntially the extent of cortical resections in epilepsy surgery procedures without compromising seizure

217 involving 24 patients through the pediatric epilepsy surgery program at UCLA Mattel Children's Hospi

218 for the development and support of resective epilepsy surgery programmes across national healthcare s

219 ficant shift in the role of the Wada test in epilepsy surgery programmes.

220 kes advantage of the unique opportunity that epilepsy surgery provides to investigate the effects of

221 Epilepsy surgery reduced seizure activity in randomized

222 Successful outcomes in epilepsy surgery rely on the accurate localization of th

223 Imaging in the field of epilepsy surgery remains an essential tool in terms of i

224 There is an argument that epilepsy surgery remains underused, but the evidence to

225 se comprising 16 patients who have undergone epilepsy surgery, revealing rich-club structures within

226 rbid depression and the first 6 months after epilepsy surgery seem to be particular risk factors.

227 lerosis, and the systematic investigation of epilepsy surgery specimens in general.

228 Highly connected nodes in these networks are epilepsy surgery targets.

229 the clinic population, and to outcome after epilepsy surgery, than the 'Life-satisfaction' scale and

230 ography (ECoG) is routinely performed during epilepsy surgery there is little evidence that the exten

231 k/benefit ratio and of realistic outcomes of epilepsy surgery; this may help reduce the number of pat

232 outcome and drug freedom up to 5 years after epilepsy surgery, to improve presurgical decision making

233 ries in children before and after undergoing epilepsy surgery, to measure the impact of disease cours

234 ary to potentially epileptogenic lesions and epilepsy surgery, underlining the importance of function

235 for predicting the outcome of temporal lobe epilepsy surgery used qualitative visual pattern classif

236 Epilepsy surgery was less effective when there were extr

237 Resective epilepsy surgery was shown to be cost-effective with an

238 The frequency of seizure-free outcome after epilepsy surgery was similar for infants, children, and

239 diagnostic modalities remains suboptimal in epilepsy surgery, we evaluated whether interictal spike

240 4 female) undergoing invasive monitoring for epilepsy surgery were implanted with microelectrodes.

241 Changes in brain function from pre- to post-epilepsy surgery were quantified in a group of temporal

242 Biopsies from epilepsy surgery were used for fine-scale and tomographi

243 An important example is epilepsy surgery, where the perturbation in question is

244 we probed specimens (n = 10) resected during epilepsy surgery with a panel of 13 antibodies recognizi

245 Thus, 100 patients who underwent two-stage epilepsy surgery with chronic electrocorticography recor

246 nterictal (18)F-FDG PET, followed by 2-stage epilepsy surgery with chronic subdural electrocorticogra

247 in a large cohort of patients who underwent epilepsy surgery with hemimegalencephaly or focal cortic

248 FRs can thus be used for tailoring epilepsy surgery with repeated intraoperative ECoG measu

249 systematically evaluate all meta-analyses of epilepsy surgery with seizure freedom as the primary out

250 All patients underwent epilepsy surgery, with the operations based on ictal EEG

251 ts that HD-EEG may be of clinical utility in epilepsy surgery work-up.

252 e epilepsy is the most common indication for epilepsy surgery, yet little is known about its 'natural